IRWD PE Ratio & Valuation, Is IRWD Overvalued

Historical Valuation

Ironwood Pharmaceuticals Inc (IRWD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.02 is considered Undervalued compared with the five-year average of 14.49. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 15.71 to 20.15 according to relative valuation method. Compared to the current price of 3.67 USD , Ironwood Pharmaceuticals Inc By Undervalued By 76.68%.

Relative Value

Fair Zone

15.71-20.15

Current Price：3.67

76.68%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Ironwood Pharmaceuticals Inc (IRWD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Ironwood Pharmaceuticals Inc (IRWD) has a current Price-to-Book (P/B) ratio of -2.63. Compared to its 3-year average P/B ratio of -2.12, the current P/B ratio is approximately 24.00% higher. Relative to its 5-year average P/B ratio of 1.14, the current P/B ratio is about -330.06% higher. Ironwood Pharmaceuticals Inc (IRWD) has a Forward Free Cash Flow (FCF) yield of approximately 9.74%. Compared to its 3-year average FCF yield of 21.65%, the current FCF yield is approximately -55.02% lower. Relative to its 5-year average FCF yield of 18.17%, the current FCF yield is about -46.40% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IRWD competitors is 31.75, providing a benchmark for relative valuation. Ironwood Pharmaceuticals Inc Corp (IRWD.O) exhibits a P/S ratio of 2.02, which is -93.63% above the industry average. Given its robust revenue growth of -47.31%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IRWD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IRWD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IRWD currently overvalued or undervalued?

Ironwood Pharmaceuticals Inc (IRWD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.02 is considered Undervalued compared with the five-year average of 14.49. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 15.71 to 20.15 according to relative valuation method. Compared to the current price of 3.67 USD, Ironwood Pharmaceuticals Inc is Undervalued By 76.68%.

What is Ironwood Pharmaceuticals Inc (IRWD) fair value?

IRWD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 15.71 to 20.15 according to relative valuation method.

How does IRWD's valuation metrics compare to the industry average?

The average P/S ratio for IRWD's competitors is 31.75, providing a benchmark for relative valuation. Ironwood Pharmaceuticals Inc Corp (IRWD) exhibits a P/S ratio of 2.02, which is -93.63% above the industry average. Given its robust revenue growth of -47.31%, this premium appears unsustainable.

What is the current P/B ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Mar 11 2026?

As of Mar 11 2026, Ironwood Pharmaceuticals Inc (IRWD) has a P/B ratio of -2.63. This indicates that the market values IRWD at -2.63 times its book value.

What is the current FCF Yield for Ironwood Pharmaceuticals Inc (IRWD) as of Mar 11 2026?

As of Mar 11 2026, Ironwood Pharmaceuticals Inc (IRWD) has a FCF Yield of 9.74%. This means that for every dollar of Ironwood Pharmaceuticals Inc's market capitalization, the company generates 9.74 cents in free cash flow.

What is the current Forward P/E ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Mar 11 2026?

As of Mar 11 2026, Ironwood Pharmaceuticals Inc (IRWD) has a Forward P/E ratio of 6.83. This means the market is willing to pay $6.83 for every dollar of Ironwood Pharmaceuticals Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Mar 11 2026?

As of Mar 11 2026, Ironwood Pharmaceuticals Inc (IRWD) has a Forward P/S ratio of 2.02. This means the market is valuing IRWD at $2.02 for every dollar of expected revenue over the next 12 months.

IRWD Valuation